Response to Letter to the Editor
Alberto Busetto, Giorgio Cannone, Luigi Lione, Alessandro Bonis, Vincenzo Verzeletti, Michele Battistel, Alessandro Rebusso, Samuele Nicotra, Andrea Dell'Amore, Federico Rea

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsLymphatic Disorders and Treatments · Congenital Diaphragmatic Hernia Studies · Congenital Anomalies and Fetal Surgery
Dear Editor,
1
It is with great pleasure that we read the letter addressing our recent article about the challenges and treatment strategies of chylothorax after thoracic surgery [1]. You correctly emphasize the role of MR lymphography as a valuable tool in the diagnostic algorithm of chylothorax [2]. It presents great advantages, such as the non‐invasiveness and the absence of administration of a contrast agent, reducing the risks for the patient. Moreover, it allows precise spatial resolution of the lymphatic system morphology and anomalies and the visualization of small collaterals associated with lymphatic leak localization [3].
While we agree with the usefulness of unenhanced MR lymphography in this context, in our article we proposed an overview of the most common strategies used for chylothorax treatment. MR lymphography is important in the diagnostic part of the algorithm, but it is not a treatment modality. In our surgical ward we have to be focused on rapid diagnostic assessment, and as Lipiodol lymphoangiography has also the potential to be a vessel sealant and thus to definitively treat the leakage, we prefer using this technique. Moreover, intraoperative management of relapsing and persistent leaks still requires a contrast agent for proper visualization of the leakage site, such as ICG [4]. As you already have stated, MR lymphography does not allow for the dynamic study of the lymphatic flow, and it becomes difficult to use it in the planning of the eventual future surgery [3, 4, 5].
Patients with chylothorax often undergo prolonged hospitalization, adversely affecting both clinical outcomes and the efficient allocation of healthcare resources. In this context, it is fair to state that MR machines are mainly used for elective diagnostics and it is difficult to obtain urgent MR diagnostics for hospitalized patients. Furthermore, MR is time consuming and has higher costs than lymphography. Most of all, this examination technique requires highly experienced and trained staff for interpretation of the findings, which are not promptly available in most institutions.
In conclusion, while we fully acknowledge the diagnostic value of unenhanced MR lymphography in the evaluation of chylothorax, its integration into routine clinical practice remains challenging in our setting due to organizational and staffing constraints. Ultimately, a balanced approach that considers both diagnostic precision and practical feasibility is essential. We appreciate the opportunity to engage in this important dialogue and welcome further discussion aimed at optimizing the management of this complex condition.
Author Contributions
Alberto Busetto: conceptualization, data curation, methodology, investigation, writing – original draft. Giorgio Cannone: conceptualization, data curation, writing – review and editing. Luigi Lione: methodology, investigation. Alessandro Bonis: methodology, validation. Vincenzo Verzeletti: supervision, formal analysis, writing – review and editing. Michele Battistel: validation, visualization. Alessandro Rebusso: data curation, supervision, writing – review and editing. Samuele Nicotra: supervision, formal analysis, writing – review and editing. Andrea Dell'Amore: project administration, methodology, supervision, writing – review and editing. Federico Rea: supervision, formal analysis, project administration, writing – review and editing.
Conflicts of Interest
The authors declare no conflicts of interest.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1A. Busetto , G. Cannone , L. Lione , et al., “Chylothorax After Thoracic Surgery: How We Manage It,” Thoracic Cancer 16 (2025): e 70036, 10.1111/1759-7714.70036.40051248 PMC 11885794 · doi ↗ · pubmed ↗
- 2L. Arrivé , “Response Letter to “Management of Chylothorax Following Thoracic Surgery” by Busetto et al,” Thoracic Cancer 16 (2025): e 70103, 10.1111/1759-7714.70103.40468681 PMC 12138036 · doi ↗ · pubmed ↗
- 3C. Cholet , C. Delalandre , L. Monnier‐Cholley , F. Le Pimpec‐Barthes , S. El Mouhadi , and L. Arrivé , “Nontraumatic Chylothorax: Nonenhanced MR Lymphography,” Radiographics 40, no. 6 (2020): 1554–1573, 10.1148/rg.2020200044.33001788 · doi ↗ · pubmed ↗
- 4L. Lione , A. Busetto , A. Bonis , et al., “Management of Postoperative Left‐Sided Chylothorax Using Indocyanine Green Fluorescence‐Guided VATS,” Complications 1, no. 3 (2024): 79–82, 10.3390/complications 1030012. · doi ↗
- 5V. Verzeletti , A. Busetto , G. Cannone , et al., “Perioperative Outcomes in Redo VATS for Pulmonary Ipsilateral Malignancy: A Single Center Experience,” European Journal of Surgical Oncology 49, no. 12 (2023): 107255, 10.1016/j.ejso.2023.107255.37939598 · doi ↗ · pubmed ↗
